Naya Capital Management UK Ltd. Purchases New Stake in Aetna Inc (AET)
Naya Capital Management UK Ltd. purchased a new stake in shares of Aetna Inc (NYSE:AET) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 335,780 shares of the company’s stock, valued at approximately $61,616,000. Aetna makes up about 6.1% of Naya Capital Management UK Ltd.’s portfolio, making the stock its 6th largest holding.
Several other institutional investors and hedge funds have also recently made changes to their positions in AET. Cornerstone Advisors Inc. boosted its stake in shares of Aetna by 263.6% during the 1st quarter. Cornerstone Advisors Inc. now owns 600 shares of the company’s stock worth $101,000 after acquiring an additional 435 shares during the last quarter. Bruderman Asset Management LLC purchased a new position in shares of Aetna during the 1st quarter worth $118,000. Kaizen Advisory LLC boosted its stake in shares of Aetna by 143.9% during the 2nd quarter. Kaizen Advisory LLC now owns 766 shares of the company’s stock worth $141,000 after acquiring an additional 452 shares during the last quarter. Clearwater Capital Advisors LLC purchased a new position in shares of Aetna during the 1st quarter worth $154,000. Finally, CSat Investment Advisory L.P. purchased a new position in shares of Aetna during the 2nd quarter worth $162,000. 83.51% of the stock is owned by institutional investors.
AET opened at $203.03 on Friday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 0.74. Aetna Inc has a fifty-two week low of $149.69 and a fifty-two week high of $204.20. The firm has a market cap of $66.60 billion, a P/E ratio of 20.59, a PEG ratio of 1.75 and a beta of 0.68.
Several brokerages have recently weighed in on AET. ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a research note on Tuesday, June 26th. Cantor Fitzgerald reiterated a “buy” rating and set a $202.00 price target on shares of Aetna in a research note on Thursday, August 2nd. Finally, Zacks Investment Research cut shares of Aetna from a “hold” rating to a “sell” rating in a research note on Tuesday, July 24th. Eight investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Aetna currently has a consensus rating of “Hold” and a consensus target price of $200.38.
Aetna Company Profile
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Featured Story: Google Finance Portfolio Tips and Tricks
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.